Carteolol (versus unexposed)

Exposed non-exposed, cohort studies

Study Country
Study period
Study design
Data source Exposure definition Non-exposure definition Exposition period Sample size
(exposed/unexposed) Or (case / control)
Remarks Risk of bias
Ishibashi
2017
Japan
2000 - 2016
retrospective cohort
15 Japanese institutions. Pregnancies in long QT patients with Carteolol therapy. unexposed, sick
Pregnancies in long QT patients without β-blocker therapy.
during pregnancy (anytime or not specified) 2 / 94 Exposure: 1 carteolol (15mg/day, 0.25mg/ kg/day) in the text but 2 in the Supplemental Table2. The considered number of exposure was 2 because it corresponds to the 'right' sum of exposure to beta-blockers.
All data were collected with checking their maternity record book.

Case-control studies

Study Country
Study period
Study design
Data source Case Control Exposition Exposition period Sample size
(exposed/unexposed) Or (case / control)
Remarks Risk of bias

Risk of bias: : NA;   : low;   : moderate;   : serious;   : critical;   : unclear;  

Empty. There are no case-control studies available for this drug.

master protocol